Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

Coffee and Cancer—Again?

June 2018 Vol 4 No 3

In March 2018, a California judge ruled that coffee sellers must now label their products with a warning about the potential risk for cancer associated with coffee, because the chemical called “acrylamide,” which is produced when coffee beans are roasted, has been linked to cancer in rats. In response, the American Institute for Cancer Research (AICR; www.aicr.org) published an article to explain that hundreds of scientific studies show that coffee is not associated with any cancer risk.1 “Although acrylamide increases cancer risk for lab animals at higher doses, the studies that have measured levels of acrylamide in the blood in humans, including in high coffee consumers, have shown no hint of increased cancer risk,” the AICR says.1

According to the AICR, coffee contains compounds that can block carcinogens (cancer-causing substances) and may help to kill cancer cells; therefore, those who like drinking coffee should not worry, the AICR notes. It adds that some studies indicate that coffee may actually lower the risk for some types of cancer.1 However, adding a lot of sugar and other sweeteners to the coffee can increase the risk for some cancers, because being overweight or obese increases the risk for 11 types of cancer.

“On a ‘cancer worry’ scale from 0 to 10, coffee should be solidly at 0 and smoking at 10; they should not have similar warning labels,” wrote Edward L. Giovannucci, MD, ScD, Professor of Nutrition at Harvard School of Public Health in Boston.2

References

1. American Institute for Cancer Research. Coffee and your cancer risk. May 3, 2018. www.aicr.org/enews/2018/05-may/enews-coffee-and-your-cancer-risk.html.
2. Giovannucci EL. Coffee doesn’t need cancer warning. March 30, 2018. http://blog.aicr.org/2018/03/30/coffee-doesnt-need-cancer-warning/.

Recommended For You